Cara Therapeutics | Creditori Commerciali

Prezzo Delle Azioni
3.95
Cambio Giornaliero
-0.01 -0.25%
Mensile
2.33%
Annuale
-70.28%
Q1 Previsione
3.87




Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 10.9M 10.84M 2025-12
Alterity Therapeutics Limited AUD 1.27M 1.81M 2024-12
Assertio Holdings USD 14.66M 3.81M 2025-09
Cara Therapeutics USD 2.42M 2.42M 2025-06
Cassava Sciences USD 46.09M 3.27M 2025-09
Chugai Pharma JPY 127.25B 48.35B 2025-12
Cipla INR 30.35B 1.98B 2025-09
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 9.12M 7.33M 2025-09
CSL USD 3.17B 290M 2025-12
Grifols EUR 1.04B 183.31M 2025-06
Halozyme Therapeutics USD 20.9M 5.54M 2025-12
J&J USD 11.99B 2.37B 2025-12
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Pacira USD 15.15M 2.54M 2025-12
Pfizer USD 5.02B 142M 2025-09
RedHill Biopharma USD 835K 7.03M 2025-06
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12


Cara Therapeutics Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2026.